Ser71 Phosphorylation Inhibits Actin-Binding of Profilin-1 and Its Apoptosis-Sensitizing Activity
Journal Article
·
· Frontiers in Cell and Developmental Biology
- Washington Univ., St. Louis, MO (United States). Dept. of Medicine. Division of Oncology; National Clinical Research Center for Child Health, Hangzhou (China). Zhejiang Univ. School of Medicine. The Children’s Hospital. Dept. of Surgical Oncology; OSTI
- Washington Univ., St. Louis, MO (United States). Dept. of Medicine. Division of Oncology
- Washington Univ., St. Louis, MO (United States). School of Medicine. Dept. of Cell Biology and Physiology; Univ. of Houston, TX (United States). MD Anderson Cancer Center
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States). Life Sciences Division
The essential actin-binding factor profilin-1 (Pfn1) is a non-classical tumor suppressor with the abilities toboth inhibit cellular proliferation and augment chemotherapy-induced apoptosis. Besides actin, Pfn1 interacts with proteins harboring the poly-L-proline (PLP) motifs. Our recent work demonstrated that both nuclear localization and PLP-binding are required for tumor growth inhibition by Pfn1, and this is at least partially due to Pfn1 association with the PLP-containing ENL protein in the Super Elongation Complex (SEC) and the transcriptional inhibition of pro-cancer genes. In this paper, by identifying a phosphorylation event of Pfn1 at Ser71 capable of inhibiting its actin-binding and nuclear export, we provide in vitro and in vivo evidence that chemotherapy-induced apoptotic sensitization by Pfn1 requires its cytoplasmic localization and actin-binding. With regard to tumor growth inhibition byPfn1, our data indicate a requirement for dynamic actin association and dissociation rendered by reversible Ser71phosphorylation and dephosphorylation. Furthermore, genetic and pharmacological experiments showed that Ser71 of Pfn1 can be phosphorylated by protein kinase A (PKA). Taken together, our data provide novel mechanistic insights into the multifaceted anticancer activities of Pfn1 and how they are spatially-defined in the cell and differentially regulated by ligand-binding.
- Sponsoring Organization:
- American Cancer Society; Breast Cancer Research Foundation (BCRF); National Institutes of Health (NIH); National Natural Science Foundation of China (NSFC); Susan G. Komen Foundation; USDOD; USDOE Office of Science (SC)
- Grant/Contract Number:
- AC02-05CH11231
- OSTI ID:
- 1816029
- Journal Information:
- Frontiers in Cell and Developmental Biology, Journal Name: Frontiers in Cell and Developmental Biology Vol. 9; ISSN 2296-634X
- Publisher:
- Frontiers Media S.A.Copyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Modulation of actin structure and function by phosphorylation of Tyr-53 and profilin binding
Profilin facilitates PKCε activation by accelerating ATP supply
Computational modeling highlights the role of the disordered Formin Homology 1 domain in profilin-actin transfer
Journal Article
·
Wed Aug 27 00:00:00 EDT 2008
· Proc. Natl. Acad. Sci. USA
·
OSTI ID:1006789
Profilin facilitates PKCε activation by accelerating ATP supply
Journal Article
·
Fri Dec 14 23:00:00 EST 2018
· Biochemical and Biophysical Research Communications
·
OSTI ID:23136912
Computational modeling highlights the role of the disordered Formin Homology 1 domain in profilin-actin transfer
Journal Article
·
Sat May 12 20:00:00 EDT 2018
· FEBS Letters
·
OSTI ID:1543443